A long-term follow-up study of interferon treatment for chronic hepatitis C in Japanese patients with congenital bleeding disorders

European Journal of Haematology

Volumn 57, Issue 2, 1996, Pages 165-170

  Yamada, M ^a   Fukuda, Y ^c   Koyama, Y ^c   Nakano, I ^c   Urano, F ^c   Isobe, K ^a   Takamatsu, J ^a   Imoto, M ^b   Hayakawa, T ^a  

^a NAGOYA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b FUJITA HEALTH UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c NONE

Author keywords

Chronic hepatitis C; Congenital bleeding disorder; Hemophilia; Hepatitis C virus; Interferon

Indexed keywords

ALPHA INTERFERON;

ADULT; ARTICLE; BLEEDING DISORDER; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FOLLOW UP; HEPATITIS C; HUMAN; JAPAN; MALE; PRIORITY JOURNAL; SUBCUTANEOUS DRUG ADMINISTRATION;

EID: 0029787088     PISSN: 09024441     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0609.1996.tb01355.x     Document Type: Article

References (29)

1. FLETCHER ML, TROWELL JM, CRASKE J, PAVIER K, RIZZA CR. Non-A non-B hepatitis after transfusion of factor VIII in infrequently treated patients. Br Med J 1983: 287: 1754-1757.
2. KERNOFF PBA, LEE CA, KARAYIANNIS P, THOMAS HC. High risk of non-A non-B hepatitis after a first exposure to volunteer or commercial clotting factor concentrates: effects of prophylactic immune serum globulin. Br J Haematol 1985: 60: 469-479.
3. MANNUCCI PM, COLOMBO M, RIZZETTO M. Nonprogressive course of non-A, non-B hepatitis in multitransfused hemophiliacs. Blood 1982: 60: 655-658.
4. WHITE II GC, ZEITLER KD, LESESNE HR, et al. Chronic hepatitis in patients with hemophilia A: histologic studies in patients with intermittently abnormal liver function tests. Blood 1982: 60: 1259-1262.
5. HAY CRM, PRESTON FE, TRIGER DR, UNDERWOOD JCE. Progressive liver disease in haemophilia: an understated problem? Lancet 1985: 1: 1495-1498.
6. ISOBE K, IMOTO M, FUKUDA Y, et al. Hepatatis C virus infection and genotypes in Japanese hemophiliacs. Liver 1995: 15: 131-134.
7. MAKRIS M, PRESTON FE, TRIGER DR, et al. Hepatitis C antibody and chronic liver disease in haemophilia. Lancet 1990: 335: 1117-1119.
8. ALLAIN JP, DAILEY SH, LAURIAN Y, et al. Evidence for persistent hepatitis C virus infection in hemophiliacs. J Clin Invest 1991: 88: 1672-1679.
9. KIYOSAWA K, SODEYAMA T, TANAKA E, et al. Interrelationship of blood transfusion, non-A, non-B hepatitis and hepatocellular carcinoma: analysis by detection of antibody to hepatitis C virus. Hepatology 1990: 12: 671-675.
10. DAVIS GL, BALART LA, SCHIFF ER, et al. Treatment of chronic hepatitis C with recombinant interferon alfa: a multicenter randomized, controlled trial. N Engl J Med 1989: 321: 1501-1506.
11. DI BISCEGLIE AM, MARTIN P, KASSIANIDES C, et al. Recombinant interferon alfa therapy for chronic hepatitis C: a randomized, double-blind, placebo-controlled trial. N Engl J Med 1989: 321: 1506-1510.
12. SHINDO M, DI BISCEGLIE AM, CHEUNG L, et al. Decrease in serum hepatitis C viral RNA during alpha-interferon therapy for chronic hepatitis C. Ann Intern Med 1991: 115: 700-704.
13. REICHARD O, GLAUMANN H, FRYDÉN A, et al. Two-year biochemical, virological, and histological follow-up in patients with chronic hepatitis C responding in a sustained fashion to interferon alfa-2b treatment. Hepatology 1995: 21: 918-922.
14. YUKI N, HAYASHI N, KASAHARA A, et al. Pretreatment viral load and response to prolonged interferon-α course for chronic hepatitis C. J Hepatol 1995: 22: 457-463.
15. HAYASHI J, OHMIYA M, KISHIHARA Y, et al. A statistical analysis of predictive factors of response to human lymphoblastoid interferon in patients with chronic hepatitis C. Am J Gastroenterol 1994: 89: 2151-2156.
16. TSUBOTA A, CHAYAMA K, IKEDE K, et al. Factors predictive of response to interferon-α therapy in hepatitis C virus infection. Hepatology 1994: 19: 1088-1094.
17. LEE CA, KERNOFF PBA, KARAYIANNIS P, THOMAS HC. Interferon therapy for chronic non-A non-B and chronic delta liver disease in haemophilia. Br J Haematol 1989: 72: 235-238.
18. MAKRIS M, PRESTON FE, TRIGER DR, UNDERWOOD JCE, WESTLAKE L, ADELMAN MI. A randomized controlled trial of recombinant interferon-α in chronic hepatitis C in hemophiliacs. Blood 1991: 78: 1672-1677.
19. BRESTERS D, MAUSER-BUNSCHOTEN EP, CUYPERS HTM, et al. Long term treatment of chronic hepatitis C with interferon alfa-2b: disappearance of HCV-RNA in a pilot study of eight haemophilia patients. Gut 1993 (Suppl): S124-S125.
20. YOSHIKAWA M, FUKUI H, KOJIMA H, et al. Interferon treatment of chronic hepatitis C in patients with hemophilia or von Willebrand's disease in Japan. J Gastroenterol 1995: 30: 367-371.
21. OKAMOTO H, OKADA S, SUGIYAMA Y, et al. Detection of hepatitis C virus RNA by a two-stage polymerase chain reaction with two pairs of primers deduced from the 5′-noncoding region. Jpn J Exp Med 1990: 60: 215-222.
22. KATO N, YOKOSUKA O, HOSODA K, ITO Y, OHTO M, OMATA M. Quantification of hepatitis C virus by competitive reverse transcription-polymerase chain reaction: increase of the virus in advanced liver disease. Hepatology 1993: 18: 16-20.
23. OKAMOTO H, SUGIYAMA Y, OKADA S, et al. Typing hepatitis C virus by polymerase chain reaction with type-specific primers: application to clinical surveys and tracing infectious sources. J Gen Virol 1992: 73: 673-679.
24. SIMMONDS P, ALBERTI A, ALTER HJ, et al. A proposed system for the nomenclature of hepatitis C viral genotypes. Hepatology 1994: 19: 1321-1324.
25. DE GROOTE J, DESMET VJ, GEDIGK P, et al. A classification of chronic hepatitis. Lancet 1968: 2: 626-628.
26. KNODELL RG, ISHAK KG, BLACK WC, et al. Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis. Hepatology 1981: 1: 431-435.
27. ALBERTI A, MORSICA G, CHEMELLO L, et al. Hepatitis C viraemia and liver disease in symptom-free individuals with anti-HCV. Lancet 1992: 340: 697-698.
28. HAKOZAKI Y, SHIRAHAMA T, KATOU M, NAKAGAWA K, OBA K, MITAMURA K. A controlled study to determine the optimal dose regimen of interferon-α 2b in chronic hepatitis C. Am J Gastroenterol 1995: 90: 1246-1249.
29. IINO S, HINO K, KUROKI T, SUZUKI H, YAMAMOTO S. Treatment of chronic hepatitis C with high-dose interferon α-2b. Dig Dis Sci 1993: 38: 612-618.